GSK-3 Research Group

Welcome to our lab!

The research in our laboratory is focused on the molecular pathways regulated by the serine/threonine kinase, glycogen synthase kinase-3 (GSK-3), and their implications in pathological disorders. In recent years GSK-3 is emerged as a drug discovery target involved in diabetes, neurodegenerative and affective disorders, including Alzheimer’s disease (AD), Parkinson’s disease, and bipolar disorder. Our aim is to identify mechanisms linking hyperactivity of GSK-3 with these pathologies.

Our laboratory employ multidisciplinary research platforms to address frontier challenges in disease mechanisms and potential solutions. We use molecular and cellular biology, in vitro assays, animal models, and computational tools.

Wish to join us?

Open Positions for Post-doctoral Fellows: For a new grant-supported project in drug development and its implications in neurodegenerative diseases.We are looking for highly motivated individuals for a challenging project that combines basic and industry-oriented research.

We are currently seeking for highly motivated Ph.D and M.Sc students.For a new and innovative project in drug discovery and drug development: Implications in neurodegenerative disorders.